Articles > Popular publications > PR Newswire press releases > October-December 1997 > Monday, December 1

Article: Imitrex(R) Nasal Spray Now Available for People With Migraine in the U.S.

Article from:
PR Newswire
Article date:
December 1, 1997
Copyright 
 
  -- Innovative Therapy in New Formulation Expands "Family" 
of Treatment Choices for Migraine Sufferers --

RESEARCH TRIANGLE PARK, N.C., Nov. 28 /PRNewswire/ -- The nasal spray form of Imitrex(R) (sumatriptan), the innovative therapy for the acute treatment of migraine, is now available to consumers in the United States by prescription. Imitrex has been available in the U.S. since 1993 in subcutaneous injection form, and since 1995 in tablet form. The medication was developed and is marketed by Glaxo Wellcome Inc.

Imitrex Nasal Spray expands the family of Imitrex products to provide a wide range of treatment options for people ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Glaxo Wellcome Inc. Receives Clearance to Market Imitrex(R) ...
PR Newswire;  September 2, 1997 ;     700+ words ... ... injection form and tablet form. Imitrex Nasal Spray will expand the family of Imitrex ... hours with a 20 mg dose.) Imitrex Nasal Spray will be available to consumers by prescription in October. Imitrex Nasal Spray is indicated for the acute ...

Article: New 'Zomig' Nasal Spray Provides Migraine Sufferers ...
PR Newswire;  October 28, 2002 ;     700+ words ... ... both rapidly and reliably. 'Zomig' Nasal Spray offers patients a highly effective ... The clinical trial data for Zomig Nasal Spray suggest that this new formulation offers ... needles. For the first time, 'Zomig' Nasal Spray offers a real alternative -- a patient ...

Article: ZOMIG(R) (zolmitriptan) Nasal Spray Provides Total ...
PR Newswire;  January 13, 2005 ;     700+ words ... ... treatment with ZOMIG(R) (zolmitriptan) Nasal Spray produced a significantly higher rate ... significantly higher in patients using ZOMIG Nasal Spray than those using placebo (14.5 ... third of the patients using ZOMIG Nasal Spray experienced total symptom relief by ...

Article: NovaDel Announces Positive Results from Pharmacokinetic Study of ...
Business Wire;  September 28, 2006 ;     700+ words ... ... for the currently marketed Imitrex nasal spray as a proxy for therapeutic ... well tolerated. Comparison to Imitrex Nasal Spray Published Data Time to the ... literature for the same dose of the Imitrex nasal spray (6 min. vs. 20 min ...

Article: New Data Demonstrate ZOMIG(R) (zolmitriptan) Nasal ...
PR Newswire;  April 27, 2004 ;     700+ words ... ... treatment with ZOMIG(R) (zolmitriptan) Nasal Spray provides a very fast onset of action ... migraine relief received from ZOMIG Nasal Spray, with the majority of patients willing ... 15 minutes after using zolmitriptan nasal spray." Early Efficacy and Excellent Tolerability ...

Article: FDA Approves New ZOMIG(R) (zolmitriptan) Nasal ...
PR Newswire;  October 1, 2003 ;     700+ words ... ... approved ZOMIG(R) (zolmitriptan) Nasal Spray (5.0 mg) for the acute treatment ... relief seen as early as 15 minutes, this nasal spray offers a fast acting treatment option ... migraine.(2) In addition, ZOMIG Nasal Spray has an excellent Nasokinetic profile ...

Article: NEW NASAL SPRAY TREATMENT FOR POSTMENOPAUSAL ...
PR Newswire;  August 18, 1995 ;     700+ words ... ... clearance to market MIACALCIN(R) Nasal Spray (calcitonin-salmon) for the treatment ... 20 million American women, MIACALCIN Nasal Spray offers a new approach in the delivery ... therapy. Clinical studies with MIACALCIN Nasal Spray have shown significant increases in ...

Article: Zomig(R) Nasal Spray Now Available to Consumers; - ...
PR Newswire;  October 1, 2003 ;     700+ words ... ... launch of ZOMIG(R) (zolmitriptan) Nasal Spray (5.0, 2.5, 1.0, 0.5 mg ... with or without aura in adults, ZOMIG Nasal Spray provides migraine relief as early as ... within 15-30 minutes).(1) ZOMIG Nasal Spray is thought to have a rapid onset of ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives